Sign In
Get Clay Free →

Suggestions

    Peter Maag

    Executive Chairman at CareDx, Inc.

    Peter Maag, Ph.D., is a seasoned executive with over 20 years of experience in the pharmaceutical and diagnostics industries.2 He served as a Board Member at MolecularMD from 2012 to 2020.35 Currently, Dr. Maag is the Chief Executive Officer of Kyverna Therapeutics, Inc. and an Independent Director at CareDx, Inc.3

    Dr. Maag's career highlights include:

    • CEO of Kyverna Therapeutics (current position)23
    • Executive Chairman, President, and CEO of CareDx (2012-2021)12
    • President of Novartis Diagnostics14
    • Country President for Novartis in Germany and Korea14
    • Head of Strategy for Novartis Pharmaceuticals1
    • Associate Principal at McKinsey & Company13

    Dr. Maag received his Ph.D. from the University of Berlin, Germany, and studied pharmaceutical sciences in Heidelberg and London.12 His LinkedIn username is petermaag.6

    Highlights

    Peter Maag, Ph.D. - The Personalized Medicine Coalition
    Oct 1 · businesswire.com
    XDx Appoints Peter Maag as President and CEO - Business Wire

    Related Questions

    What are Peter Maag's main responsibilities at MolecularMD?
    How did Peter Maag contribute to the growth of CareDx?
    What is Peter Maag's background in pharmaceutical sciences?
    What other companies is Peter Maag currently affiliated with?
    How did Peter Maag's role at Novartis influence his career?